Paper14241
Efficacy of caffeine in treatment of apnea in the low-birth-weight infant.
Aranda JV and 3 others. J Pediatr, 1977. Cited by 264 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. Papers, record 14241. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14241
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apnea | Major topic |
| Caffeine | Major topic |
| Infant, Low Birth Weight | Major topic |
| Infant, Newborn, Diseases | Major topic |
| Carbon Dioxide | |
| Drug Evaluation | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Infant, Newborn |
Source PubMed
Cited by67
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 264 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,640,008 | Advancing Neonatal Drug Development Through Industry-Academic Collaboration. | J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42640008 | PubMed |
| 42,244,880 | Developmental age and clinical illness drive in vivo variability of CYP1A2 ontogeny and caffeine metabolism in preterm neonates. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42244880 | PubMed |
| 41,965,906 | Caffeine prevents airway hyperreactivity in a neonatal mouse model of continuous positive airway pressure. | Pediatr Res | 2026 | https://conductscience.org/library/papers/41965906 | PubMed |
| 41,540,197 | Putative mechanisms of caffeine as a neuroprotectant in preterm infants. | Pediatr Res | 2026 | https://conductscience.org/library/papers/41540197 | PubMed |
| 41,165,563 | Caffeine-associated reduction in patent ductus arteriosus is mediated in part by adenosine receptor antagonism. | Am J Physiol Heart Circ Physiol | 2025 | https://conductscience.org/library/papers/41165563 | PubMed |
| 41,152,486 | Apnoea duration and changes in cardiorespiratory and cerebrovascular responses in preterm neonates: a systematic review and meta-analysis. | Pediatr Res | 2026 | https://conductscience.org/library/papers/41152486 | PubMed |
| 41,020,198 | Caffeine Therapy Reduces Severe Retinopathy of Prematurity in Neonates with Gestational Age between 23 and 28 Weeks. | Ophthalmol Sci | 2026 | https://conductscience.org/library/papers/41020198 | PubMed |
| 40,620,533 | What is the Role of Caffeine in the Management of Preterm Infants? | Curr Treat Options Pediatr | 2025 | https://conductscience.org/library/papers/40620533 | PubMed |
| 40,083,438 | Caffeine use in preterm neonates: national insights into Turkish NICU practices. | Front Pediatr | 2025 | https://conductscience.org/library/papers/40083438 | PubMed |
| 39,334,735 | Caffeine: The Story beyond Oxygen-Induced Lung and Brain Injury in Neonatal Animal Models-A Narrative Review. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39334735 | PubMed |
| 39,045,901 | Strategies for cessation of caffeine administration in preterm infants. | Cochrane Database Syst Rev | 2024 | https://conductscience.org/library/papers/39045901 | PubMed |
| 38,643,263 | Caffeine: how early is too early? | Pediatr Res | 2024 | https://conductscience.org/library/papers/38643263 | PubMed |
| 38,553,606 | Caffeine for apnea and prevention of neurodevelopmental impairment in preterm infants: systematic review and meta-analysis. | J Perinatol | 2024 | https://conductscience.org/library/papers/38553606 | PubMed |
| 38,470,639 | The Babyccino: The Role of Caffeine in the Prevention of Acute Kidney Injury in Neonates-A Literature Review. | Healthcare (Basel) | 2024 | https://conductscience.org/library/papers/38470639 | PubMed |
| 38,429,570 | Caffeine pharmacokinetics following umbilical vein injection during delayed cord clamping in preterm lambs. | Pediatr Res | 2024 | https://conductscience.org/library/papers/38429570 | PubMed |
| 37,718,322 | What do we know about the sleep effects of caffeine used to treat apnoea of prematurity? A systematic review of the literature. | Mol Cell Pediatr | 2023 | https://conductscience.org/library/papers/37718322 | PubMed |
| 35,692,738 | Is Early Preventive Caffeine Safe and Effective in Premature Neonates? A Clinical Trial. | Int J Pediatr | 2022 | https://conductscience.org/library/papers/35692738 | PubMed |
| 35,356,441 | Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence? | Front Pediatr | 2022 | https://conductscience.org/library/papers/35356441 | PubMed |
| 35,351,252 | Clinical effect of different maintenance doses of caffeine citrate in the treatment of preterm infants requiring assisted ventilation: a pilot multicenter study. | Zhongguo Dang Dai Er Ke Za Zhi | 2022 | https://conductscience.org/library/papers/35351252 | PubMed |
| 34,381,359 | Caffeine for the Pharmacological Treatment of Apnea of Prematurity in the NICU: Dose Selection Conundrum, Therapeutic Drug Monitoring and Genetic Factors. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34381359 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14241
GET https://conductscience.org/api/papers/v1/14241/cited_by?page=2